HMOX1 and asthma: We also found that in the PVE treatment group, the expression of antioxidant enzymes Nrf2 and HO-1 had significantly increased in lung tissue as well as the BALF and that treatment decreased the level of oxidative stress marker MDA in the BALF and inhibited the activation of MAPK signaling that is a feature of asthma.